Pharmacokinetic drug–drug interactions between 1,4-dihydropyridine calcium channel blockers and statins: factors determining interaction strength and relevant clinical risk management
Yi-Ting Zhou,1 Lu-Shan Yu,2 Su Zeng,2 Yu-Wen Huang,1 Hui-Min Xu,1 Quan Zhou11Department of Pharmacy, the Second Affiliated Hospital, School of Medicine, 2Department of Pharmaceutical Analysis and Drug Metabolism, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang Province, P...
Saved in:
Main Authors: | Zhou YT (Author), Yu LS (Author), Zeng S (Author), Huang YW (Author), Xu HM (Author), Zhou Q (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2013-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
THE EFFICACY AND SAFETY OF DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKERS IN HYPERTENSIVE PATIENTS: AMLODIPINE PLACE
by: M. V. Lebedeva, et al.
Published: (2015) -
THE EFFICACY AND SAFETY OF DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKERS IN HYPERTENSIVE PATIENTS: AMLODIPINE PLACE
by: M. V. Lebedeva, et al.
Published: (2015) -
Dihydropyridine-derived calcium channel blocker as a promising anti-hantavirus entry inhibitor
by: Bin Wang, et al.
Published: (2022) -
Mechanisms and the clinical relevance of complex drug–drug interactions
by: Roberts AG, et al.
Published: (2018) -
The uricosuric effects of dihydropyridine calcium channel blockers in vivo using urate under-excretion animal models
by: Takayuki Hori, et al.
Published: (2018)